- Home
- LTC vs AMLX Comparison
LTC vs AMLX Comparison
Compare LTC & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LTC | AMLX |
|---|---|---|
| Founded | 1992 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LTC | AMLX |
|---|---|---|
| Price | $38.42 | $12.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $40.00 | $21.56 |
| AVG Volume (30 Days) | 294.3K | ★ 923.5K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.96% | N/A |
| EPS Growth | 23.53 | ★ 65.46 |
| EPS | ★ 0.48 | N/A |
| Revenue | $262,854,000.00 | ★ $380,786,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $79.05 | ★ N/A |
| Revenue Growth | 25.26 | ★ 1612.94 |
| 52 Week Low | $33.64 | $4.64 |
| 52 Week High | $40.80 | $18.61 |
Technical Indicators
Market Signals| Indicator | LTC | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 49.88 | 27.68 |
| Support Level | $37.57 | $12.13 |
| Resistance Level | $39.80 | $15.37 |
| Average True Range (ATR) | 0.65 | 0.79 |
| MACD | -0.03 | -0.41 |
| Stochastic Oscillator | 40.24 | 0.00 |
Price Performance
Historical ComparisonAbout LTC LTC Properties Inc.
LTC Properties Inc is a real estate investment trust. It invests in seniors housing and health care properties, mainly through ownership, sale-leasebacks, mortgage financing, joint ventures, construction financing, and structured finance solutions, including preferred equity, bridge, and mezzanine lending. The company's investment portfolio comprises several properties located throughout the USA, the majority of which are seniors housing and skilled nursing properties. The firm conducts and manages its business as two operating segments: Real Estate Investments, which generates maximum revenue, and SHOP.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.